The modification of the ethanol withdrawal syndrome in rats by di-n-propylacetate
- PMID: 781711
- DOI: 10.1007/BF00421381
The modification of the ethanol withdrawal syndrome in rats by di-n-propylacetate
Abstract
Di-n-propylacetate (DPA), a drug known to increase brain gamma-aminobutyric acid (GABA) levels and to inhibit GABA-transamine (GABA-T) activity, was administered during the ethanol withdrawal period to rats made physically dependent upon ethanol. Under all conditions tested, 400 mg DPA/kg injected i.p. significantly reduced the withdrawal hyperexcitable state induced by acoustic stimulation. The effect was seen as early as 30 min after the administration of DPA and lasted for at least 2 hrs. Readministration of the same dose of DPA 6.5 hrs after its initial injection again mitigated withdrawal symptoms. A 200 mg/kg dose of DPA was significantly effective for only 1 hr after its administration. Neither dose led to mortality or observable tranquilization. The results suggest that DPA may be a useful agent in the control of the hyperexcitable state induced by ethanol withdrawal and that the GABA system may be involved in this state.
Similar articles
-
Effect of di-n-propylacetate on the 'binding of GABA to synaptosome-enriched fraction of rat cerebral cortex.Psychopharmacology (Berl). 1977 Aug 16;53(3):255-7. doi: 10.1007/BF00492360. Psychopharmacology (Berl). 1977. PMID: 408853
-
Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.Biochem Pharmacol. 1976 Feb 15;25(4):413-7. doi: 10.1016/0006-2952(76)90343-9. Biochem Pharmacol. 1976. PMID: 779794 No abstract available.
-
[On the mechanism of action of valproid acid].Arzneimittelforschung. 1977;27(5):1081-2. Arzneimittelforschung. 1977. PMID: 328017 German.
-
Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review.Epilepsia. 1975 Nov;16(4):549-73. doi: 10.1111/j.1528-1157.1975.tb04738.x. Epilepsia. 1975. PMID: 812693 Review.
-
A role for valproate in the treatment of sedative-hypnotic withdrawal and for relapse prevention.Alcohol Alcohol. 2000 Jul-Aug;35(4):319-23. doi: 10.1093/alcalc/35.4.319. Alcohol Alcohol. 2000. PMID: 10905994 Review.
Cited by
-
The effects of ethanol, phenobarbital, and baclofen on ethanol withdrawal in the rhesus monkey.Psychopharmacology (Berl). 1980;70(2):201-8. doi: 10.1007/BF00435315. Psychopharmacology (Berl). 1980. PMID: 6776581
-
Induction of physical dependence on and tolerance to ethanol in rats fed a new nutritionally complete and balanced liquid diet.Psychopharmacology (Berl). 1980;68(1):55-9. doi: 10.1007/BF00426650. Psychopharmacology (Berl). 1980. PMID: 6771798
-
Electroencephalographic and behavioral correlates in rats during repeated ethanol withdrawal syndromes.Psychopharmacology (Berl). 1984;83(2):140-6. doi: 10.1007/BF00429722. Psychopharmacology (Berl). 1984. PMID: 6431463
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous